Diabetes mellitus of the maturity onset type, which cannot be controlled by diet alone.
- The dosage of gliclazide should be carefully titrated to maintain optimal control at the various possible dose levels. Dosage should be initiated at 40 mg (1/2 tablet) daily and may be increased if necessary up to 320 mg (four tablets) daily. Doses up to 160 mg daily may be taken in a single dose but preferably at the same time each morning. Doses in excess of 160 mg should be taken in divided doses in the morning and evening.
- In general, the dosage will depend on the severity of the glycaemia with ongoing adjustments made in order to obtain the optimal response at the lowest dosage.
- Treatment with gliclazide does not obviate the necessity of maintaining standard dietary regulations.
This medication is contra-indicated in the following cases:
- Hypersensitivity to gliclazide, other sulphonylureas, sulfonamides, or to any of the excipients
- Type I diabetes, diabetic keto-acidosis, diabetic pre-coma and coma;
- Severe renal or hepatic insufficiency
- Treatment with miconazole
- Pregnancy and lactation
- Liver or kidney problems
- Hypoglycemia
- Alcohol intake
- Pregnancy and breast-feeding
- Driving and using machines
- Hypoglycemia
- Gastrointestinal disturbances
- Dermatologic reactions
- Hematologic reactions
- Metabolic reactions
- Endocrine reactions
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light.
NID 40 mg: 10×10’s
NID 80 mg: 10×10’s
